• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便微生物群移植的应用范围正在扩大,不再局限于肠道疾病。

Fecal microbiota transplantation broadening its application beyond intestinal disorders.

作者信息

Xu Meng-Que, Cao Hai-Long, Wang Wei-Qiang, Wang Shan, Cao Xiao-Cang, Yan Fang, Wang Bang-Mao

机构信息

Meng-Que Xu, Hai-Long Cao, Wei-Qiang Wang, Shan Wang, Xiao-Cang Cao, Fang Yan, Bang-Mao Wang, Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin 300052, China.

出版信息

World J Gastroenterol. 2015 Jan 7;21(1):102-11. doi: 10.3748/wjg.v21.i1.102.

DOI:10.3748/wjg.v21.i1.102
PMID:25574083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4284325/
Abstract

Intestinal dysbiosis is now known to be a complication in a myriad of diseases. Fecal microbiota transplantation (FMT), as a microbiota-target therapy, is arguably very effective for curing Clostridium difficile infection and has good outcomes in other intestinal diseases. New insights have raised an interest in FMT for the management of extra-intestinal disorders associated with gut microbiota. This review shows that it is an exciting time in the burgeoning science of FMT application in previously unexpected areas, including metabolic diseases, neuropsychiatric disorders, autoimmune diseases, allergic disorders, and tumors. A randomized controlled trial was conducted on FMT in metabolic syndrome by infusing microbiota from lean donors or from self-collected feces, with the resultant findings showing that the lean donor feces group displayed increased insulin sensitivity, along with increased levels of butyrate-producing intestinal microbiota. Case reports of FMT have also shown favorable outcomes in Parkinson's disease, multiple sclerosis, myoclonus dystonia, chronic fatigue syndrome, and idiopathic thrombocytopenic purpura. FMT is a promising approach in the manipulation of the intestinal microbiota and has potential applications in a variety of extra-intestinal conditions associated with intestinal dysbiosis.

摘要

如今已知肠道菌群失调是众多疾病的一种并发症。粪便微生物群移植(FMT)作为一种针对微生物群的治疗方法,对于治疗艰难梭菌感染可谓非常有效,且在其他肠道疾病中也有良好疗效。新的见解引发了人们对FMT用于管理与肠道微生物群相关的肠外疾病的兴趣。这篇综述表明,在将FMT应用于包括代谢性疾病、神经精神疾病、自身免疫性疾病、过敏性疾病和肿瘤等此前未预料到的领域这一新兴科学领域,正处于令人兴奋的时期。通过输注来自瘦捐赠者的微生物群或自体采集的粪便,对代谢综合征患者进行了FMT的随机对照试验,结果发现,瘦捐赠者粪便组的胰岛素敏感性增加,同时产生丁酸盐的肠道微生物群水平也有所提高。FMT的病例报告在帕金森病、多发性硬化症、肌阵挛性肌张力障碍、慢性疲劳综合征和特发性血小板减少性紫癜中也显示出良好效果。FMT在调控肠道微生物群方面是一种很有前景的方法,并且在与肠道菌群失调相关的各种肠外病症中具有潜在应用价值。

相似文献

1
Fecal microbiota transplantation broadening its application beyond intestinal disorders.粪便微生物群移植的应用范围正在扩大,不再局限于肠道疾病。
World J Gastroenterol. 2015 Jan 7;21(1):102-11. doi: 10.3748/wjg.v21.i1.102.
2
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?粪便微生物移植在肠道疾病以外有潜在的应用吗?
Biomed Res Int. 2019 Jul 29;2019:3469754. doi: 10.1155/2019/3469754. eCollection 2019.
3
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.粪菌移植改变肠道菌群失调并不能诱导慢性活动性溃疡性结肠炎患者缓解。
Inflamm Bowel Dis. 2013 Sep;19(10):2155-65. doi: 10.1097/MIB.0b013e31829ea325.
4
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.肠道微生物群发病机制及粪便微生物群移植治疗炎症性肠病
World J Gastroenterol. 2014 Oct 28;20(40):14805-20. doi: 10.3748/wjg.v20.i40.14805.
5
Fecal microbiota transplantation for the management of Clostridium difficile infection.粪菌移植用于艰难梭菌感染的治疗
Infect Dis Clin North Am. 2015 Mar;29(1):109-22. doi: 10.1016/j.idc.2014.11.009.
6
Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.肠道微生物组的改变:粪便微生物群移植和益生菌治疗艰难梭菌感染及其他疾病。
Expert Rev Gastroenterol Hepatol. 2013 Sep;7(7):615-28. doi: 10.1586/17474124.2013.832501.
7
Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?粪便微生物群移植(FMT)对功能性胃肠疾病(FGID)患者是否为一种有效的治疗方法?
Neurogastroenterol Motil. 2015 Jan;27(1):19-29. doi: 10.1111/nmo.12479. Epub 2014 Nov 25.
8
Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.富含双歧杆菌的粪便供体可能是肠易激综合征患者粪便微生物群移植成功的一个积极预测指标。
Digestion. 2017;96(1):29-38. doi: 10.1159/000471919. Epub 2017 Jun 21.
9
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.粪便微生物群移植治疗溃疡性结肠炎及艰难梭菌感染以外的其他胃肠道疾病:最新进展
Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765.
10
[Recommendations for the use of faecal microbiota transplantation "stool transplantation": consensus of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society of Infectious Diseases and Tropical Medicine].[粪便微生物群移植“粪便移植”的使用建议:奥地利胃肠病学和肝病学会(ÖGGH)与奥地利传染病和热带医学学会合作达成的共识]
Z Gastroenterol. 2014 Dec;52(12):1485-92. doi: 10.1055/s-0034-1385562. Epub 2014 Dec 4.

引用本文的文献

1
Role of gut microbiota in neuroinflammation: a focus on perioperative neurocognitive disorders.肠道微生物群在神经炎症中的作用:聚焦围手术期神经认知障碍
Front Cell Infect Microbiol. 2025 Jul 7;15:1582909. doi: 10.3389/fcimb.2025.1582909. eCollection 2025.
2
Gut microbiota and tuberculosis infection: interaction and therapeutic potential.肠道微生物群与结核病感染:相互作用及治疗潜力
Gut Microbes. 2025 Dec;17(1):2531201. doi: 10.1080/19490976.2025.2531201. Epub 2025 Jul 14.
3
The Multifactorial Pathogenesis of Endometriosis: A Narrative Review Integrating Hormonal, Immune, and Microbiome Aspects.子宫内膜异位症的多因素发病机制:整合激素、免疫和微生物组方面的叙述性综述
Medicina (Kaunas). 2025 Apr 27;61(5):811. doi: 10.3390/medicina61050811.
4
Gut-heart axis: cardiac remodeling and heart failure in the context of inflammatory bowel disease and dysbiosis.肠-心轴:炎症性肠病和肠道菌群失调背景下的心脏重塑与心力衰竭
Am J Physiol Gastrointest Liver Physiol. 2025 Jul 1;329(1):G122-G137. doi: 10.1152/ajpgi.00016.2025. Epub 2025 May 19.
5
The potential therapeutic approaches targeting gut health in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a narrative review.针对肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)肠道健康的潜在治疗方法:一项叙述性综述
J Transl Med. 2025 May 11;23(1):530. doi: 10.1186/s12967-025-06527-x.
6
Evaluation of extended-spectrum -lactamase producing bacteria in feces of shelter dogs as a biomarker for altered gut microbial taxa and functional profiles.评估收容所犬类粪便中产超广谱β-内酰胺酶细菌作为肠道微生物分类群和功能谱改变的生物标志物。
Front Microbiol. 2025 Mar 24;16:1556442. doi: 10.3389/fmicb.2025.1556442. eCollection 2025.
7
Obesity-Associated Colorectal Cancer.肥胖相关性结直肠癌。
Int J Mol Sci. 2024 Aug 14;25(16):8836. doi: 10.3390/ijms25168836.
8
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response.超越肠道:肿瘤内微生物组对肿瘤发生和治疗反应的影响。
Cancer Commun (Lond). 2024 Oct;44(10):1130-1167. doi: 10.1002/cac2.12597. Epub 2024 Aug 1.
9
Autoimmunity, New Potential Biomarkers and the Thyroid Gland-The Perspective of Hashimoto's Thyroiditis and Its Treatment.自身免疫、新的潜在生物标志物与甲状腺——桥本甲状腺炎及其治疗的视角。
Int J Mol Sci. 2024 Apr 26;25(9):4703. doi: 10.3390/ijms25094703.
10
Improvements in Gut Microbiome Composition and Clinical Symptoms Following Familial Fecal Microbiota Transplantation in a Nineteen-Year-Old Adolescent With Severe Autism.一名19岁重度自闭症青少年接受家族性粪便微生物群移植后肠道微生物群组成及临床症状的改善
J Med Cases. 2024 May;15(4-5):82-91. doi: 10.14740/jmc4209. Epub 2024 May 2.

本文引用的文献

1
Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea.麻省总医院临床病例. 病例 25-2014. 一名 37 岁男性,溃疡性结肠炎伴血便。
N Engl J Med. 2014 Aug 14;371(7):668-75. doi: 10.1056/NEJMcpc1400842.
2
Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.复发性艰难梭菌感染:肠道微生物群的重要性。
World J Gastroenterol. 2014 Jun 21;20(23):7416-23. doi: 10.3748/wjg.v20.i23.7416.
3
Is Crohn's disease ready for fecal microbiota transplantation?克罗恩病适合进行粪便微生物群移植吗?
J Clin Gastroenterol. 2014 Aug;48(7):582-3. doi: 10.1097/MCG.0000000000000155.
4
Restoring the gut microbiome for the treatment of inflammatory bowel diseases.恢复肠道微生物群以治疗炎症性肠病。
World J Gastroenterol. 2014 Apr 7;20(13):3468-74. doi: 10.3748/wjg.v20.i13.3468.
5
Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile.粪便微生物群移植诱导克罗恩病性结肠炎缓解及粪便微生物谱的相关变化
J Clin Gastroenterol. 2014 Aug;48(7):625-8. doi: 10.1097/MCG.0000000000000131.
6
Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection.严重失调的微生物生态系统的重置:粪便移植治疗复发性艰难梭菌感染
ISME J. 2014 Aug;8(8):1621-33. doi: 10.1038/ismej.2014.13. Epub 2014 Feb 27.
7
T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria.干燥综合征抗原 A(SSA)/Ro60 与口腔、肠道、皮肤和阴道细菌之间的 T 细胞表位模拟。
Clin Immunol. 2014 May-Jun;152(1-2):1-9. doi: 10.1016/j.clim.2014.02.004. Epub 2014 Feb 19.
8
Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.肠道微生物群和粪便移植作为治疗胰岛素抵抗和 2 型糖尿病的方法。
Clin Exp Immunol. 2014 Jul;177(1):24-9. doi: 10.1111/cei.12293.
9
Microbial translocation and cardiometabolic risk factors in HIV infection.HIV感染中的微生物易位与心脏代谢危险因素
AIDS Res Hum Retroviruses. 2014 Jun;30(6):514-22. doi: 10.1089/aid.2013.0280. Epub 2014 Mar 25.
10
Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.胆碱和甜菜碱的预后价值取决于肠道微生物群产生的代谢物氧化三甲胺。
Eur Heart J. 2014 Apr;35(14):904-10. doi: 10.1093/eurheartj/ehu002. Epub 2014 Feb 3.